Search the web
Welcome, Guest
[Sign Out, My Account]

Tuesday, April 21 2015 4:31am ET - U.S. Markets open in 4 hours and 59 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Composite Value: 1828.6
Today's Change: -0.45%
S&P 500: +0.92%
chart for
[Biotechnology (^YHOh788)]
Biotechnology News
Inovio Pharmaceuticals and Roche Initiate Clinical Trial for Inovio's DNA Immunotherapy to Treat Chronic Hepatitis B Infection
1 hour, 31 minutes ago (GlobeNewswire)
PLYMOUTH MEETING, Pa. -- Inovio Pharmaceuticals, Inc. announced today that it has initiated a phase I trial to evaluate Inovio's DNA immunotherapy in patients who are chronically infected with hepatitis ...
Final Glance: Biotechnology companies - (AP)
Epizyme Presents Preclinical Research Providing Deeper Understanding of Multiple Cancer Targets - (Business Wire)
More News on Biotechnology: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
SHIRE [SHP.L] +0.82% $3333.6 B
GILEAD SCIENCES [GILD.MX] +0.97% $2311.6 B
AMGEN [AMGN.MX] +3.39% $1831.3 B
AMGEN DRN [AMGN34.SA] 0.00% $392.2 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
04/20/15 SVA Sinovac Biotech Ltd Q4 2014 Earnings Release
04/21/15 AMGN Amgen Inc Earnings Call (Q1 2015)
04/21/15 ILMN Illumina Inc Earnings Call (Q1 2015)
More Upcoming Events...
Recent Events
Date Co Event
04/20/15 ADRO ADURO BIOTECH, INC. coverage initiated by ROTH Capital
04/20/15 BCRX BioCryst Pharmaceuticals, Inc. upgraded by BofA/Merrill
04/20/15 MDVN Medivation, Inc. downgraded by Credit Suisse
More Recent Events...
Sponsor Results
Biotechnology News
Stay Ahead of IT Threats. Don't Let Hacker Creativity Go Unmatched.
Business Services
Find Business Services Here!
Shimadzu Life Science
A new way of thinking in the health and life science industries
(What's This?)
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:13,134B
Price / Earnings:102.8
Price / Book:23.0
Net Profit Margin (mrq):17.7%
Price To Free Cash Flow (mrq):74.4
Return on Equity:14.6%
Total Debt / Equity:66.9
Dividend Yield:1.8%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?